Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в січні 1997 (uk)
- articolo scientifico (pubblicato il 1997) (it)
- im Januar 1997 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 1997 (ast)
- artikull shkencor i botuar më 01 janar 1997 (sq)
- scientific article published on 01 January 1997 (en)
|
publication date
| |
publication date
| |
cites work
| |
cites work
| - Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
- Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers
- Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174
- Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients
- Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing
- Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist
- DuP 532: a second generation of nonpeptide angiotensin II receptor antagonists
- Pharmacology of Nonpeptide Angiotensin II Receptor Antagonists
- Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography
- High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine. I. DuP 532 (L-694,492)
- Angiotensin II measurement with high-affinity monoclonal antibodies
- Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan
- The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogs
|
author name string
| |
author name string
| - Chiou R
- Brunner HR
- Christ DD
- Nussberger J
- Biollaz J
- Goldberg MR
- Piguet V
- Lo MW
- Carides A
- Amit O
- Furtek CI
|
rdfs:label
| - DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (en)
- DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (nl)
- DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (sq)
|
skos:prefLabel
| - DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (en)
- DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (nl)
- DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (sq)
|
name
| - DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (en)
- DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (nl)
- DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (sq)
|
title
| |
title
| - DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/S0009-9236(97)90182-X
|
is about
of | |
is cites work
of | |
is cites work
of | |